ES2189799T3 - Metodo para detectar sindrome de down utilizando muestras de sangre seca. - Google Patents

Metodo para detectar sindrome de down utilizando muestras de sangre seca.

Info

Publication number
ES2189799T3
ES2189799T3 ES94906738T ES94906738T ES2189799T3 ES 2189799 T3 ES2189799 T3 ES 2189799T3 ES 94906738 T ES94906738 T ES 94906738T ES 94906738 T ES94906738 T ES 94906738T ES 2189799 T3 ES2189799 T3 ES 2189799T3
Authority
ES
Spain
Prior art keywords
trisomy
hcg
blood samples
down syndrome
free beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94906738T
Other languages
English (en)
Inventor
James N Macri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2189799T3 publication Critical patent/ES2189799T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN METODO PARA DETECTAR EL SINDROME DE DOWN (TRISOMY 21), TRISOMY 13, TRISOMY 18 Y OTRAS ANOMALIAS DE LOS CROMOSOMAS DURANTE LA INVESTIGACION PRENATAL, POR ANALISIS DE UNA MUESTRA DE SANGRE SECA DE UNA MUJER EMBARAZADA. EN PARTICULAR, LA PRESENTE INVENCION SE REFIERE A UN METODO PARA MEJORAR LA EFICACIA DE DETECCION EN LA INVESTIGACION CONTRA ANOMALIAS MEDIANTE MEDICION DE LA CANTIDAD DE GONADOTROPIN CORIONICO HUMANO BETA LIBRE (HCG) Y FORMAS MARCADAS O FRAGMENTADAS O ABERRANTES DE (HCG) BETA LIBRE, TODO LO CUAL ESTA REFERENCIADO MEDIANTE ESTA APLICACION COMO (HCG) BETA LIBRE EN MUESTRAS DE SANGRE SECA DE UNA MUJER EMBARAZADA.
ES94906738T 1992-08-07 1993-08-06 Metodo para detectar sindrome de down utilizando muestras de sangre seca. Expired - Lifetime ES2189799T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/925,683 US5252489A (en) 1989-01-17 1992-08-07 Down syndrome screening method utilizing dried blood samples

Publications (1)

Publication Number Publication Date
ES2189799T3 true ES2189799T3 (es) 2003-07-16

Family

ID=25452087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94906738T Expired - Lifetime ES2189799T3 (es) 1992-08-07 1993-08-06 Metodo para detectar sindrome de down utilizando muestras de sangre seca.

Country Status (10)

Country Link
US (1) US5252489A (es)
EP (1) EP0667958B1 (es)
JP (1) JP3529777B2 (es)
KR (1) KR100344085B1 (es)
AT (1) ATE230488T1 (es)
AU (1) AU688279B2 (es)
CA (1) CA2141870C (es)
DE (1) DE69332610T2 (es)
ES (1) ES2189799T3 (es)
WO (1) WO1994003805A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5594637A (en) * 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
US5427953A (en) * 1993-11-08 1995-06-27 The Detroit Medical Center Blood testing method
US5432097A (en) * 1993-11-09 1995-07-11 Yourno; Joseph Method for recovery of blood cells from dried blood spots on filter paper
US5674727A (en) * 1994-08-31 1997-10-07 Cole; Laurence A. Human chorionic gonadotropin beta-subunit nicking enzyme
US5606164A (en) * 1996-01-16 1997-02-25 Boehringer Mannheim Corporation Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
DK0923730T3 (da) * 1996-09-06 2009-02-09 Univ Yale Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin
US6066464A (en) * 1996-12-10 2000-05-23 Diagnostic Systems Laboratories, Inc. Immunoassay of IGF family of peptides, their binding proteins and related molecules in dried whole blood filter paper spots
US6177283B1 (en) * 1997-05-28 2001-01-23 Flexsite Diagnostics, Inc. Diagnostic assay
US6265223B1 (en) 1997-05-28 2001-07-24 Flexsite Diagnostics, Inc. Diagnostic assay
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
US6677123B1 (en) * 1998-02-03 2004-01-13 Wako Pure Chemical Industries, Ltd. Process for detecting increased risk of fetal chromosomal abnormality
CA2353066A1 (en) * 1998-12-29 2000-07-06 Flexsite Diagnostics, Inc. Remote site urine collection device and method of use
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
AU2001266733A1 (en) * 2000-06-07 2001-12-17 Duke University Diagnostic methods for pompe disease and other glycogen storage diseases
US7244233B2 (en) * 2003-07-29 2007-07-17 Ntd Laboratories, Inc. System and method for utilizing shape analysis to assess fetal abnormality
CA2576646C (en) * 2003-07-29 2011-02-08 Ntd Laboratories, Inc. System and method for assessing fetal abnormality based on landmarks
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
CA2602963A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
WO2007121276A2 (en) * 2006-04-12 2007-10-25 Biocept, Inc. Enrichment of circulating fetal dna
US20100240054A1 (en) * 2008-09-22 2010-09-23 Biocept, Inc. Identification and isolation of fetal cells and nucleic acid
US20100216250A1 (en) * 2009-02-20 2010-08-26 Lopez Mary Frances Methods for Predicting Trisomy 21 in a Fetus
GB2496122A (en) * 2011-10-31 2013-05-08 Ge Healthcare Bio Sciences Ab Biological sample preservation on paper
EP4289356A3 (en) 2015-09-09 2024-02-28 Drawbridge Health, Inc. Devices for sample collection, stabilization and preservation
GB2576635B (en) 2017-01-10 2020-08-05 Drawbridge Health Inc Devices, systems, and methods for sample collection
SG11202112776QA (en) * 2019-05-17 2021-12-30 Irepertoire Inc Immunorepertoire wellness assessment systems and methods
WO2022091418A1 (ja) * 2020-11-02 2022-05-05 株式会社ヘルスケアシステムズ 尿検体を保存するための試薬、キット及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4123224A (en) * 1975-12-17 1978-10-31 American Home Products Corporation Diagnostic test device
JPS54126723A (en) * 1978-03-23 1979-10-02 Teikoku Hormone Mfg Co Ltd Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
GR850899B (es) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
ATE91182T1 (de) * 1987-07-09 1993-07-15 3I Res Expl Ltd Praenatales screening fuer downs-syndrom.
US5037305A (en) * 1988-11-16 1991-08-06 Vivigen, Inc. Graphic method for reporting risk to a patient
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
DK0666477T3 (da) * 1989-01-17 2004-02-23 Jn Macri Technologies Llc Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening
US5103836A (en) * 1990-02-28 1992-04-14 Epitope, Inc. Oral collection device and kit for immunoassay

Also Published As

Publication number Publication date
JPH08500181A (ja) 1996-01-09
EP0667958A1 (en) 1995-08-23
AU5003593A (en) 1994-03-03
DE69332610T2 (de) 2003-10-16
DE69332610D1 (de) 2003-02-06
US5252489A (en) 1993-10-12
WO1994003805A1 (en) 1994-02-17
AU688279B2 (en) 1998-03-12
EP0667958B1 (en) 2003-01-02
EP0667958A4 (en) 1997-07-16
KR100344085B1 (ko) 2002-11-04
CA2141870A1 (en) 1994-02-17
CA2141870C (en) 2004-10-19
JP3529777B2 (ja) 2004-05-24
ATE230488T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
ES2189799T3 (es) Metodo para detectar sindrome de down utilizando muestras de sangre seca.
WO2003001964A3 (en) Measurement testing of blood specimens
CA2264840A1 (en) Prenatal screening for down's syndrome using hyperglycosylated gonadotropin
DE69729186T2 (de) Einstufiger immunoasssay mit einem trockenen "alles-in-einem"-reagens
DE69931910D1 (en) Pränatales screening für downs-syndrom
CA2141668A1 (en) Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
CA2181190A1 (en) Mesoscale Sample Preparation Device and Systems for Determination and Processing of Analytes
WO2000055368A3 (en) Probe/mobility modifier complexes for multiplex nucleic acid detection
EP1333274A3 (en) Up-converting reporters for biological and other assays using laser excitation techniques
IT1270130B (it) Strumento diagnostico automatizzato in particolare per l'analisi di campioni in pacchi di prova per un analita
BR9707214A (pt) Processo para analisar uma amostra de constituição desconhecida por meio de um aparelho analìtico.
DE59009230D1 (de) Biegenmomentfreie Einspannvorrichtung für Prüfkörper oder Proben, insbesondere Keramikproben.
GB8914563D0 (en) Detecting or quantifying multiple analytes using labelling techniques
Qin et al. Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free β-subunit of human chorionic gonadotrophin
ATE226415T1 (de) Leberfunktionstest
GB8726271D0 (en) Protein glycosylation assay
DE69525400T2 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
DK115489D0 (da) Foerfoedselscreening for down's syndrom
SE8904100D0 (sv) New analysis method
IT8921434A0 (it) Metodo e dispositivo fotometrico per analisi di campioni trattati con reattivi fluorescenti.
WO2002057743A3 (en) Methods of analyzing and sorting one or more analytes
IS3331A7 (is) Aðferð til að nota skönnunarsmásjá og myndgreini til efnagreingingar, með því að mæla meðal sætistölu frumefna í efnafösum, sem innihalda létt frumefni.
Feret et al. Effect of Sample Surface Integrity on X-ray Fluorescence Analysis of Aluminum Alloys
RU98121220A (ru) Способ установления натуральности вина
赵右更 et al. PRENATAL DIAGNOSIS Ⅱ. AMNIOTIC FLUID ACETYLCHOLINESTERASE ISOENZYME PATTERNS AND ALPHA-FETOPROTEIN FOR PRENATAL DIAGNOSIS